BU-NOT-SET

CONTACT US
Advanced Bio is advancing rAAV production
  • Biologics
  • Manufacturing
Recipharm_Advanced_Bio_Virus
White paper
Advanced Bio Is advancing LNP formulation
  • Biologics
  • Manufacturing
Recipharm_AdvancedBio_RNA
White paper
Optimising drug formulation: The critical role of granulation
  • Drug product
  • Manufacturing
powder
White paper
Overcoming fixed-dose combination challenges for ALS
  • Drug product
  • Manufacturing
Recipharm_API
Case study
What’s shaping the future of pharma?
  • Industry trends
Vials
Video
Mastering tech-transfer: Turning complexity into competitive advantage
  • Drug product
  • Manufacturing
ReciPredict_people in a z
Insight
Four ways ReciPredict can transform your pharma manufacturing
  • Drug product
  • Manufacturing
logo
Insight
An expert’s guide to analytical services
  • Analytical chemistry
  • Industry trends
people in a lab
Insight
How lyophilisation can help overcome mRNA stability challenges
  • Drug product
  • Manufacturing
jars
Insight
Poster
  • Drug substance
Recipharm and Oncopeptides: Successful collaboration in the development of melflufen, a peptidase-potentiated alkylating agent in clinical trials
Fact sheet
  • Analytical chemistry
Recipharm Analytical Solutions™
Fact sheet
  • Analytical chemistry
Impurity identification
Fact sheet
  • Analytical chemistry
Stability studies
Fact sheet
  • Analytical chemistry
Extractables & leachables testing
Insight
  • Industry trends
Pharmaceutical mergers and acquisitions: opportunities and drivers for CDMOs
Insight
  • Industry trends
Global expansion in the CDMO field
Fact sheet
  • Drug product
Fixed dose combinations - for improved patient compliance
Insight
  • Industry trends
The current state of contract manufacturing